Dong-A Makes It Five: Accord Gears Up For US Launch After Ustekinumab Approval

Settlement Date Provides Certainty Of Launch; Amgen’s US Launch Only Months Away

 
• By Dean Rudge
  
Approved stamp on application form or business agreement document
(Shutterstock) • Source: Shutterstock

More from Generics Bulletin

More from Biosimilars